

MAZDUTIDE 10 MG INJECTION
Drug Class: Dual GLP-1 (Glucagon-Like Peptide-1)
Composition:
- Active Substance: Mazdutide
- Concentration: 10 mg/vial
Presentation: 2 mL Vial
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report
Mazdutide is an experimental dual agonist targeting both the GLP-1 and glucagon receptors, currently being studied for its advanced fat loss, metabolic regulation, and appetite suppression effects. This 10 mg peptide vial from Dragon Pharma offers a high-purity formulation intended for advanced weight management protocols and research-based performance enhancement.
Mazdutide mimics the effects of GLP-1 analogs like semaglutide but with an added glucagon receptor effect, amplifying energy expenditure while reducing food intake. See clinical data on Mazdutide's metabolic impact in human trials.
Its dual-agonist activity positions Mazdutide as a next-generation metabolic peptide for those who have plateaued with standard GLP-1 therapies.
Reconstitute with 1–2 mL of bacteriostatic water. Dosage protocols vary, but initial studies suggest a starting dose of 2.5–5 mg per week, titrating up to 10 mg weekly. It is typically injected subcutaneously once every 7 days.
Due to its appetite-suppressing properties, many users report natural caloric restriction and improved diet adherence while on cycle.
For advanced weight loss or body recomposition, Mazdutide may be combined with other Dragon Pharma peptides:
This dual-action weight-loss compound from Dragon Pharma is gaining attention in clinical and performance circles alike.
Common side effects may include nausea, mild fatigue, appetite suppression, and GI discomfort, especially during the first 2–3 weeks. Users sensitive to GLP-1 analogs should titrate slowly. Not recommended for those with thyroid or pancreatic disorders without physician supervision.
Mazdutide 10 mg for Sale offers a powerful and novel approach to fat loss, combining appetite control with increased metabolic activity. This research-backed Dragon Pharma Mazdutide product is ideal for those seeking clinical-grade support for weight management and insulin regulation.
Mazdutide is a dual GLP-1 and glucagon receptor agonist used for weight loss, appetite control, improved insulin sensitivity, and metabolic enhancement.
Mazdutide is typically dosed once weekly via subcutaneous injection. Common doses start at 2.5–5 mg and may increase to 10 mg weekly, based on tolerance and goals.
Yes. Mazdutide is often combined with peptides like AOD 9604, Semaglutide, or Ipamorelin to enhance fat-burning, appetite regulation, and hormonal balance.
Common side effects include nausea, decreased appetite, fatigue, and mild digestive upset. These symptoms are typically temporary and lessen with continued use.
Please log in to write Mazdutide 10 mg review.
PENTADECAPEPTIDE 2 MG INJECTION
Drug Class: Healing/Repair Peptide
Composition:
- Active Substance: Pentadecapeptide
- Concentration: 5 mg/vial
Presentation: 5 mL Vial
Form: Powder
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report
TIRZE-PEP 5 MG INJECTION
Drug Class: Dual GLP-1/GIP Peptide
Composition:
- Active Substance: Tirzepatide
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Form: Powder
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report